Association of Type 2 Diabetes Genetic Variants with Breast Cancer Survival among Chinese Women

Objective To evaluate whether the genetic susceptibility of T2D was associated with overall survival (OS) and disease-free survival (DFS) outcomes for breast cancer (BC). Methods Included in the study were 6346 BC patients who participated in three population-based epidemiological studies of BC and were genotyped with either GWAS or Exome-chip. We constructed a genetic risk score (GRS) for diabetes using risk variants identified from the GWAS catalog (http://genome.gov/gwastudies) that were associated with T2D risk at a minimum significance level of P ≤ 5.0E-8 among Asian population and evaluated its associations with BC outcomes with Cox proportional hazards models. Results During a median follow-up of 8.08 years (range, 0.01–16.95 years), 1208 deaths were documented in 6346 BC patients. Overall, the diabetes GRS was not associated with OS and DFS. Analyses stratified by estrogen receptor status (ER) showed that the diabetes GRS was inversely associated with OS among women with ER- but not in women with ER+ breast cancer; the multivariable adjusted HR was 1.38 (95% CI: 1.05–1.82) when comparing the highest to the lowest GRS quartiles. The association of diabetes GRS with OS varied by diabetes status (P for interaction <0.01). In women with history of diabetes, higher diabetes GRS was significantly associated with worse OS, with HR of 2.22 (95% CI: 1.28–3.88) for the highest vs. lowest quartile, particularly among women with an ER- breast cancer, with corresponding HR being 4.59 (95% CI: 1.04–20.28). No significant association between the diabetes GRS and OS was observed across different BMI and PR groups. Conclusions Our study suggested that genetic susceptibility of T2D was positively associated with total mortality among women with ER- breast cancer, particularly among subjects with a history of diabetes. Additional studies are warranted to verify the associations and elucidate the underlying biological mechanism.

[1]  Weiping Jia,et al.  Diabetes in Asia: epidemiology, risk factors, and pathophysiology. , 2009, JAMA.

[2]  A. Belfiore,et al.  Insulin receptors in breast cancer: Biological and clinical role , 1996, Journal of endocrinological investigation.

[3]  C. Rock,et al.  Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  N. Rothman,et al.  The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. , 2005, American journal of epidemiology.

[5]  D. Nerenz,et al.  Comorbidity and survival disparities among black and white patients with breast cancer. , 2005, JAMA.

[6]  X. Shu,et al.  Soy food intake and breast cancer survival. , 2009, JAMA.

[7]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[8]  Robert M Elashoff,et al.  Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. , 2007, Journal of the National Cancer Institute.

[9]  S. Dalton,et al.  Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990–2008 , 2012, Breast Cancer Research and Treatment.

[10]  M. De León,et al.  Insulin-like growth factors I and II receptors in the breast cancer survival disparity among African-American women. , 2010, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[11]  M. Lai,et al.  The impact of diabetes mellitus on prognosis of early breast cancer in Asia. , 2012, The oncologist.

[12]  Jong-Young Lee,et al.  Genetics of Type 2 Diabetes in East Asian Populations , 2012, Current Diabetes Reports.

[13]  Richard A. Johnson Trends in the Prevalence and Ratio of Diagnosed to Undiagnosed Diabetes According to Obesity Levels in the U.S., EW Gregg, BL Cadwell, YJ Cheng, in: Diabetes Care., 27. (2004), 2806 , 2008 .

[14]  X. Shu,et al.  Comorbidities and breast cancer survival: a report from the Shanghai Breast Cancer Survival Study , 2013, Breast Cancer Research and Treatment.

[15]  B. Zinman,et al.  The impact of diabetes on survival following breast cancer , 2008, Breast Cancer Research and Treatment.

[16]  D. Noh,et al.  Genome-Wide Association Study in East Asians Identifies Novel Susceptibility Loci for Breast Cancer , 2012, PLoS genetics.

[17]  Betsy L Cadwell,et al.  Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S. , 2004, Diabetes care.

[18]  Hao Li,et al.  Association of metformin use with cancer incidence and mortality: a meta-analysis. , 2013, Cancer epidemiology.

[19]  G. Hortobagyi,et al.  Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  Jake Yue Chen,et al.  Genome-wide meta-analysis of genetic susceptible genes for Type 2 Diabetes , 2012, BMC Systems Biology.

[21]  B. Ainsworth,et al.  Reproducibility and validity of the Shanghai Women's Health Study physical activity questionnaire. , 2003, American journal of epidemiology.

[22]  K. Dou,et al.  Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.

[23]  T. Byers,et al.  The influence of comorbidities on overall survival among older women diagnosed with breast cancer. , 2011, Journal of the National Cancer Institute.

[24]  D. Rose,et al.  The cellular and molecular mechanisms by which insulin influences breast cancer risk and progression. , 2012, Endocrine-related cancer.

[25]  J. Manson,et al.  Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. , 2010, JAMA.

[26]  R. Akdoğan,et al.  Type 2 diabetes mellitus and prognosis in early stage breast cancer women , 2012, Medical Oncology.

[27]  Z.‐J. Zhang,et al.  The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta‐analysis , 2014, Diabetes, obesity & metabolism.

[28]  G. Hortobagyi,et al.  Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  M. Lux,et al.  Diabetes and prognosis in a breast cancer cohort , 2011, Journal of Cancer Research and Clinical Oncology.

[30]  M. Trudeau,et al.  Stage at Diagnosis and Comorbidity Influence Breast Cancer Survival in First Nations Women in Ontario, Canada , 2011, Cancer Epidemiology, Biomarkers & Prevention.

[31]  J. Haines,et al.  Genome-wide association study identifies a novel breast cancer susceptibility locus at 6q25.1 , 2009, Nature Genetics.

[32]  S. Dalton,et al.  Comorbidity and survival after early breast cancer. A review. , 2012, Critical reviews in oncology/hematology.

[33]  Zumin Shi Prevalence of diabetes among men and women in China. , 2010, The New England journal of medicine.